HR
Harsh Rathnam
About Harsh Rathnam
Data last updated:
Harsh Rathnam is a Director at Avance Phytotherapies Private Limited (since 2019), Director at Novelgenix Therapeutics Private Limited (since 2022) and Designated Partner at Apiqule Pharmachem Llp (since 2021). The companies operate in Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹48.2 Lakh; the largest is Avance Phytotherapies Private Limited at ₹47.3 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Dec 2019 | 2004 | ₹47.3 Lakh (FY 2023) | Active | |
| Director | 09 Jun 2022 | 2011 | ₹93,183 (FY 2025) | Active | |
| Designated Partner | 23 Dec 2021 | 2021 | Active |
Board colleagues of Harsh Rathnam
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pundarikakshudu Kilambi | 02437252 | Avance Phytotherapies Private Limited | Director |
| Shivprakash Chinnappa | 00021083 | Avance Phytotherapies Private Limited , Novelgenix Therapeutics Private Limited and 1 more | Managing Director |
| Monika Kamalnain Verma | 02876409 | Novelgenix Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harsh Rathnam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harsh Rathnam
Harsh Rathnam currently holds 3 directorships: Avance Phytotherapies Private Limited (Director, since 11 Dec 2019, revenue ₹47.3 Lakh (FY 2023)); Novelgenix Therapeutics Private Limited (Director, since 09 Jun 2022, revenue ₹93,183 (FY 2025)); Apiqule Pharmachem Llp (Designated Partner, since 23 Dec 2021).
Harsh Rathnam was first appointed on 11 Dec 2019 as Director at Avance Phytotherapies Private Limited. The most recent appointment on record is 09 Jun 2022 at Novelgenix Therapeutics Private Limited.
The 2 current companies of Harsh Rathnam that report revenue have a combined latest revenue of ₹48.2 Lakh: Avance Phytotherapies Private Limited ₹47.3 Lakh (FY 2023); Novelgenix Therapeutics Private Limited ₹93,183 (FY 2025).
The current boards of Harsh Rathnam's companies include Pundarikakshudu Kilambi (Avance Phytotherapies Private Limited), Shivprakash Chinnappa (Avance Phytotherapies Private Limited), Monika Kamalnain Verma (Novelgenix Therapeutics Private Limited).